DJI46,923.59+0.78%
GDAXI23,564.01+0.50%
GSPC6,696.99+0.98%
HSI25,834.02+1.45%
IXIC22,366.29+1.18%
N22553,751.15-0.13%
AAPL252.29+0.87%
AMZN212.02+2.09%
CL94.12-4.65%
EURUSD1.1518+0.83%
GBPUSD1.3330+0.81%
GC5,015.40-0.91%
GOOG304.17+0.90%
JPM285.98+0.90%
META627.34+2.31%
MSFT399.04+0.88%
NVDA183.18+1.63%
TSLA396.04+1.24%
DJI46,923.59+0.78%
GDAXI23,564.01+0.50%
GSPC6,696.99+0.98%
HSI25,834.02+1.45%
IXIC22,366.29+1.18%
N22553,751.15-0.13%
AAPL252.29+0.87%
AMZN212.02+2.09%
CL94.12-4.65%
EURUSD1.1518+0.83%
GBPUSD1.3330+0.81%
GC5,015.40-0.91%
GOOG304.17+0.90%
JPM285.98+0.90%
META627.34+2.31%
MSFT399.04+0.88%
NVDA183.18+1.63%
TSLA396.04+1.24%
DJI46,923.59+0.78%
GDAXI23,564.01+0.50%
GSPC6,696.99+0.98%
HSI25,834.02+1.45%
IXIC22,366.29+1.18%
N22553,751.15-0.13%
AAPL252.29+0.87%
AMZN212.02+2.09%
CL94.12-4.65%
EURUSD1.1518+0.83%
GBPUSD1.3330+0.81%
GC5,015.40-0.91%
GOOG304.17+0.90%
JPM285.98+0.90%
META627.34+2.31%
MSFT399.04+0.88%
NVDA183.18+1.63%
TSLA396.04+1.24%
LIVE
CAN Financial Post EN

Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT)

VANCOUVER, British Columbia, March 16, 2026 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) is pleased to announce the commencement of its commercial phased rollout of the Marijuana Breath Test (“MBT”) system. This phase includes the delivery of MBT units to select commercial customers across multiple industries, […]

Mar 16, 2026 &03321616202631; 12:32 UTC financialpost.com Trending 3/5
Read original on financialpost.com ↗
Positive for markets
Sentiment score: +65/100
Moderate impact Short-term (days)
WHAT THIS MEANS
Cannabix Technologies has commenced commercial rollout of its Marijuana Breath Test (MBT) system to select customers across multiple industries. This represents a significant milestone for the company's cannabis detection technology, potentially opening new revenue streams in law enforcement, workplace safety, and transportation sectors.
AI CONFIDENCE
72% High
SENTIMENT GAUGE
NEWS POWER SCORE
AFFECTED ASSETS
BLO
BLOStock
Expected to rise
Commercial launch of MBT system represents revenue inflection point and validates technology; potential for significant market adoption in cannabis testing sector
BLOZF
BLOZFStock
Expected to rise
OTC equivalent of CSE-listed Cannabix; benefits from same commercial milestone and market expansion
8CT
8CTStock
Expected to rise
Frankfurt-listed Cannabix shares; European investors gain exposure to North American cannabis testing market opportunity
PRICE HISTORY
Loading chart...
SUGGESTED ACTION
Consider accumulating BLO/BLOZF positions on any pullbacks as commercial traction validates the MBT technology. Monitor quarterly results for customer acquisition rates and revenue ramp; successful deployment across multiple industries could drive significant upside in coming quarters.
KEY SIGNALS
Commercial product launch milestone achievedMulti-industry customer deployment initiatedRevenue generation phase beginningTechnology validation through commercial adoptionPotential regulatory approval catalyst
SECTORS INVOLVED
Cannabis TechnologySafety & Testing EquipmentLaw Enforcement TechnologyWorkplace Safety
Analysis generated on Mar 16, 2026 at 12:38 UTC
Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Financial Post. Always conduct your own research and consult a qualified financial advisor before making investment decisions.